Bristol-Myers Squibb Company
[1,2,4]triazolo[1,5-A]pyridinyl substituted indole compounds

Last updated:

Abstract:

Disclosed are compounds of Formula (I) ##STR00001## or a salt thereof, wherein R.sub.1, R.sub.2, R.sub.3, R.sub.4, R.sub.5, m, n, and p are defined herein. Also disclosed are methods of using such compounds as inhibitors of signaling through Toll-like receptor 7, or 8, or 9, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating inflammatory and autoimmune diseases.

Status:
Grant
Type:

Utility

Filling date:

15 Oct 2019

Issue date:

9 Feb 2021